Can a 13‑year‑old female safely use an intrauterine device (IUD) and what are the eligibility criteria and considerations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IUD Use in 13-Year-Old Adolescents

Yes, a 13-year-old can safely use an IUD—both copper and levonorgestrel IUDs are appropriate contraceptive options for adolescents of any age after menarche, with no age-based contraindications. 1, 2

Eligibility and Safety Classification

According to the 2024 CDC U.S. Medical Eligibility Criteria, IUDs receive a Category 2 classification for adolescents from menarche to age 20, meaning the advantages generally outweigh theoretical or proven risks. 1 This classification applies to both:

  • Copper IUD (Cu-IUD): Category 2 for ages menarche to <20 years 1
  • Levonorgestrel IUD (LNG-IUD): Category 2 for ages menarche to <20 years 1

The American Academy of Pediatrics explicitly states that IUDs are safe for nulliparous adolescents and should be presented as first-line contraceptive options alongside implants when counseling about long-acting reversible contraception (LARC). 2

Key Safety Evidence

Insertion Success Rates

Real-world data demonstrates excellent feasibility in young adolescents:

  • 96.2% first-attempt success rate in adolescents aged 13-24 years 3
  • 95.5% success rate specifically in 13-17 year olds compared to 96.3% in 18-24 year olds (no significant difference) 3
  • 95.8% success in nulliparous adolescents versus 96.7% in parous adolescents (no significant difference) 3
  • Advanced practice clinicians successfully placed 86% of IUDs, demonstrating this is not limited to physician-only procedures 3

Infection Risk

The historical concern about pelvic inflammatory disease (PID) in adolescents has been definitively refuted:

  • Infection risk occurs only during the first 21 days after insertion; IUDs do not increase STI or PID rates beyond this period 2
  • IUDs do not cause tubal infertility in nulliparous women 2
  • STI screening (gonorrhea and chlamydia) can be performed on the day of insertion unless the patient is at very high risk 2
  • If STIs are diagnosed post-insertion, treatment can be provided with the IUD in place—removal is not required 2

Absolute Contraindications

The only true contraindications to IUD placement are: 2

  • Current purulent cervicitis
  • Active gonorrhea or chlamydia infection
  • Current pelvic inflammatory disease
  • Other active pelvic infections

Important caveats:

  • Past history of PID is NOT a contraindication 2
  • HIV infection is NOT a contraindication 2
  • Immunosuppression is NOT a contraindication 2
  • Nulliparity is NOT a contraindication 2
  • Young age (<18 years) is NOT a contraindication 1, 3

Practical Considerations for Young Adolescents

Expected Outcomes

  • Continuation rates in adolescents exceed those of other hormonal methods, making IUDs particularly valuable for preventing unintended pregnancy in this high-risk population 2
  • 50% of adolescents <18 years had their IUD in place at 5 years, compared to 71.5% in 18-21 year olds 4
  • Adolescents under 18 have higher removal rates (hazard ratio 2.85) but still maintain better continuation than short-acting methods 4

Potential Complications

  • Expulsion rates: Occur in fewer than 5% overall, may be slightly higher in younger women, but age was not a statistically significant risk factor in most studies 2, 4
  • Pain with insertion: More than half of young nulliparous women report moderate to severe pain during insertion 2
  • No perforations were identified in the first 6 months in a large adolescent cohort 3
  • Only 1.8% of successful insertions required ancillary measures (paracervical block, cervical dilation) 3

Clinical Approach

When offering IUDs to 13-year-olds:

  • Counsel about pain management options before insertion, as nulliparous adolescents experience more discomfort 2, 5
  • Screen for STIs on insertion day unless very high risk (e.g., partner with known gonorrhea) 2
  • Counsel about irregular bleeding, particularly with LNG-IUD, as adolescents are less tolerant of bleeding side effects than adults 6
  • Emphasize that IUDs do not protect against STIs—consistent condom use remains essential 1, 2
  • Consider the 13.5 mg levonorgestrel IUD (Skyla) as it was specifically designed with a smaller inserter, though standard IUDs are also appropriate 2

Device Options

Three IUDs are FDA-approved and appropriate for adolescents: 2

  • 52 mg levonorgestrel IUD (Mirena): 5-year duration
  • 13.5 mg levonorgestrel IUD (Skyla): 3-year duration
  • Copper T380-A (ParaGard): 10-year duration, also serves as emergency contraception if placed within 5 days of unprotected intercourse 2

The inability to provide ancillary measures such as paracervical block or cervical dilation should not limit access to IUDs in adolescents, as these are rarely needed. 3

References

Guideline

u.s. selected practice recommendations for contraceptive use, 2024.

MMWR Recommendations and Reports, 2024

Guideline

contraception for adolescents.

Pediatrics, 2014

Research

Retrospective review of intrauterine device in adolescent and young women.

Journal of pediatric and adolescent gynecology, 2012

Research

Practical tips for intrauterine devices use in adolescents.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine, 2013

Research

Intrauterine device use is safe among nulligravidas and adolescent girls.

Acta obstetricia et gynecologica Scandinavica, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.